Mechanistically, METTL3/14 target ACLY and stearoyl-CoA desaturase 1 (SCD1), increase their expression, promote lipid metabolism and ultimately lead to HCC [114]. The gene discussed is METTL3; the disease is hepatocellular carcinoma.